semaglutide vs terzepatide A new headline out about the investigational drug tirzepatide was published this week. This medicine is a dual GLP-1/GIP agonist. The average weight loss on the high dose over 72 weeks was semaglutide vs terzepatide vs. Tirzepatide…

Height, obesity, and the risk of TMPRSS2: ERG-defined prostate cancer

When taken in moderate, medically supervised doses , it is generally considered safe for most healthy adults

Note: the effects are mild to modest as compared to injectables & topical retinoids

What follows covers the three primary injection sites in detail, the science behind absorption differences between sites, step-by-step injection technique, a complete rotation schedule you can follow week by week, troubleshooting for common injection site problems, and the specific considerations that make retatrutide administration different from other GLP-1 receptor agonists